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Smnmry The effects of the dopamine agonist 2-bromo-alpha-ergocryptine methanesulfonate (bromocriptine)
on the incidence, number and histology of gastric cancer induced by N-methyl-N'-nitro-N-nitrosoguanidine
(MNNG) were investigated in Wistar rats. Rats were given 1 or 2 mg kg-' body weight of bromocriptine
subcutaneously every other day in depot form after 25 weeks of oral treatment with MNNG. Prolonged
administration of bromocriptine at both dosages every other day resulted in a significant increase in the
incidence and number of gastric cancers of the glandular stomach by week 52. Bromocriptine treatment did
not influence the histological type of gastric cancer. but caused a significant increase in the labelling index of
epithelial cells of the antrum. These findings indicate that the dopamine agonist bromocriptine promotes
gastric carcinogenesis. and that this effect may be related to its effect in increasimg proliferation of epithelial
cells in the antral mucosa.
Dopamine plays some roles in peripheral tissues. including
the cardiovascular system (Brodde. 1982) and gastrointestinal
tract (van Neuten. 1980). In the gastrointestinal tract. dop-
amine has inhibitory effects on gastric emptying. gastric con-
traction (Valenzuela, 1976). and the pressure in the lower
oesophageal sphincter (Rattan & Goyal. 1976) and a stimu-
latory effect on colonic motility (Bueno et al.. 1984).
Dopamine is also known to inhibit gastric acid secretion
(Guldvog et al.. 1984). However. the receptor mechanisms
involved in these gastrointestinal effects of dopamine are not
well understood. Odaibo et al. (1983) found that specific
dopaminergic receptors are present in the antrum pylori of
the rat. Hernandez et al. (1987) also demonstrated specific
dopamine receptors in human gastric and duodenal mucosa.
and suggested that molecular abnormalities of these receptor
sites may be involved in the pathogenesis of important gas-
trointestinal disorders. Furthermore. Scemama et al. (1984)
detected dopamine receptors in a human colonic adenocar-
cinoma cell line (HT29) and found that their interaction with
dopamine evoked increase in protein synthesis and cAMP
accumulation. Therefore, it seemed likely that dopamine
would affect gastric carcinogenesis. To test this possibility. we
examined that effects of a dopamine agonist, bromocriptine.
on the incidence, number and histological type of adenocar-
cinomas induced by MNNG in rats.
Materials and methods
Animals
A total of 75 young (6-week-old) male Wistar rats were
purchased from Japan SLC (Shizuoka, Japan). The animals
were housed in suspended cages with a wire mesh bottom in
a room controlled at 21 ± 1'C and 40 ± 10% humidity, with
a 12:12 light/darkness cycle. Regular chow pellets (Oriental
Yeast, Tokyo. Japan) were available ad libitum.
Treatments
The animals were given drinking water containing MNNG
(Aldrich. Milwaukee, WI) for 25 weeks. The MNNG was
dissolved in deionized water at a concentration of 2 mg ml-'
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and was kept in a cool, dark place. The stock solution was
changed once a week, and was diluted to 50jig ml-' with tap
water just before use. Forty ml of MNNG solution (less than
a single rat can consume in 48 h) was given to each rat from
bottles covered with aluminum foil to prevent photolysis of
MNNG, and the bottles were replenished every other day.
From week 26. the rats were given normal tap water ad
libitum. and were randomly divided into three groups. These
groups were then given the following s.c. injections every
other day between 2 and 3 p.m. until the end of the experi-
ment in week 52: Group 1 (25 rats), the vehicle only, olive oil
at 1 ml kg-' body weight per day. Groups 2 and 3 (25 rats
each). bromocriptine (Sigma, St. Louis, MO) suspended in
olive oil at dosages of 1 or 2 mg kg-' body weight per day,
respectively.
Tissue sampling
Animals that survived for more than 50 weeks were included
in the effective numbers because the first tumour of the
glandular stomach was found in a rat in Group 1 that died in
week 50. Animals were killed at the end of the experiment in
week 52. All rats were autopsied, and the stomach and other
organs were carefully examined. The stomach was opened
along the greater curvature, pinned flat on a cork mat, and
fixed with Zamboni's solution (Stefanini et al.. 1967) for
histological examination. The fixed stomach was cut into
longitudinal strips. 3 mm wide. Specimens were embedded in
paraffin, and serial sections. 5gm thick, were stained with
hematoxylin and eosin. Sections were examined without
knowledge of which group they were from.
Histological studs
Histologically, we defined adenocarcinomas as lesions in
which neoplastic cells had penetrated the muscularis mucosae
to involve the submucosal or deeper layers. As previously
reported (Tatsuta et al.. 1988), the adenocarcinomas were
classified into very well-differentiated, well-differentiated, and
poorly differentiated types.
Measurement oflabelling index ofgastric mucosa
The labelling index of gastric mucosa was measured in weeks
30 and 52 with an immunohistochemical analysis kit for
assaying bromodeoxyuridine (BrdU) incorporation (Becton-
Dickinson. Mountain View, CA) (Gratzner, 1982; Morstyn et
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al., 1983). by the modified method described by Tada et al.
(1985). For this. five rats of each group were starved for 12 h
and then received the following s.c. injections: Group 1.
1 ml kg- I of olive oil; Groups 2 and 3. 1 and 2 mg kg-' of
bromocriptine. respectively. One hour later, the animals
received an i.p. injection of BrdU (20 mg kg-') and were
killed with ether 1 h later. The stomach was removed and
fixed in 70% ethanol for 4 h. Thin sections, 3 iLm thick. were
immersed in 2 N HCI solution for 30 min and then in 0.1 M
Na.B407. The sections were then immersed in 0.3% H.O. in
methanol for 30 min to block endogenous peroxidase activ-
ity, and treated with 10% porcine serum. The specimens were
incubated with anti-BrdU monoclonal antibody (diluted
1:20) for 2 h. washed. stained with biotin-conjugated horse
anti-mouse antibody (Vector Laboratories, Burlingame, CA:
diluted 1:200) for 30 min. and then stained with avidin-
biotin-peroxidase complex (Vector Laboratories) for 30 mi.
The reaction product was located with 3.3'-diaminobenzidine
tetra hydrochloride. Cells that contained BrdU were
identified by the presence of a dark pigment over their nuclei.
For analysis of the BrdU labelling index of gastric mucosa.
the numbers of BrdU-labelled and unlabelled cells in the
zone of proliferating cells (Eastwood & Quimby. 1983) were
counted without knowledge of which treatment group the
samples were from. The zone of proliferating cells in the
fundic mucosa was defined as a rectangular area. 250 1Am
wide, between the highest and lowest cells in a well-oriented
section. Ten such rectangular areas were selected in each rat.
In the antral mucosa. all cells below the highest labelled cell
in each pit-gland column were regarded as being within the
zone of proliferating cells. We selected 100-well oriented
columns of pits and glands in each rat. From these measure-
ments we calculated the BrdU labelling index (number of
BrdU-labelled cells total number of cells within the zone of
proliferating cells).
Measurement ofserum gastrin level and antral mucosalpH
The serum gastnrn level and antral pH were measured in
week 52. Before measurements, ten rats of each group were
starved for 12 h and then given the same s.c. injections of
olive oil (Group 1). 1 or 2 mg kg-' of bromocriptine (Groups
2 and 3) as before measurement of the labelling index. One
hour later, the rats were anaesthetised, and blood was
obtained by cardiac puncture. The stomach was then opened
and pinned flat on a cork mat, and the antral pH was
measured with a fine electrode. The gastrin content of the
serum was assayed within I week with a radioimmunoassay
kit from Dainabot Radioisotope Laboratonres. Ltd. (Tokyo,
Japan) (Tatsuta et al., 1977).
Measurements ofnorepinephrine and epinephrine in the gastric
wvall
The norepinephrine and epinephrine contents in tissues of the
gastric wall were determined in week 52 by high performance
liquid chromatography as reported (Tatsuta et al.. 1983). For
this, five rats of each group were starved for 12 h and then
the groups were given the same injections as descnrbed above.
Two hours later, the rats were killed by cervical dislocation.
Samples of about 50 mg of the fundic and antral portions of
the stomach wall were taken from each rat. homogenised
with 4.0 ml of 0.4 N perchloric acid, and centrifuged at 2.500
r.p.m. for 10 min. Each supernatant was mixed with 1.0 ml of
0.2 M disodium ethylendiamine tetraacetate (EDTA). and the
mixture was adjusted to pH 6.0 with ammonium hydroxide.
Then the mixture was added to 300 mg of purified alumina
(Woelm Neutral Active Grade I) according to the method of
Anton and Sayre (1962), and the pH was adjusted to 8.4-8.8
with ammonium hydroxide. The mixture was stirred for
5 mmn and centrifuged at 10.000 g for 10 min, and the super-
natant was aspirated and discarded. The precipitated alu-
minum was washed twice with distilled water and then
shaken vigorously with 2.5 ml of 0.4 N acetate. The mixture
was centrifuged, and the clear supernatant was transferred to
a small glass tube and lyophilised for 3 h. and the residue
was dissolved in 0.5 ml of 0.2 N acetate. Then a 50 pl aliquot
of this solution was injected into a liquid-chromatographic
column (Hitachi 301 1-C gel column, 2.6 x 250 mm. Tokyo.
Japan). Materials were eluted with 0.1 m KH.P04 containing
0.05% H3PO4 at a constant flow rate of 0.5 ml min-' at
45.0 ± 0.2'C. The effluent was mixed with the reagent for the
trihydroxyindole reaction. consisting of 0.0075% potassium
ferricyanide. 0.1% ascorbic acid. and 5 N sodium hydroxide.
The resulting fluorescent products were examined with a
highly sensitive spectro-fluorophotometer (Hitachi 650-10.
Hitachi Ltd. Tokyo).
Statistical analysis
Data were analysed by the Chi-square test or Fisher's exact
probability test or by one-way analysis of variance with
Dunn's multiple comparison (Miller. 1966; Siegel. 1956;
Snedecor & Cochran. 1967). Data are given as means ± s.e.
Results are reported as significant if the calculated P value is
less than 0.05.
Results
Incidence, number, histological tspe, and depth ofinvolvement
ofgastric cancers
Total amount of MNNG ingested for 25 weeks per rat was
170± 12mg.
Five rats in each group were killed in week 30 for deter-
mination of the labelling index of the gastric mucosa. One rat
in Group 2 and two rats in Group 1 were killed before week
50 because they became moribund. No tumours were found
in any of these animals, which were excluded from the
effective numbers.
The incidences, numbers, histological types and depths of
involvement of gastric cancers are summarised in Table I. In
Group 1 (olive oil only), gastric cancers were found in 6
(33%) of 18 rats examined, and the average number of
Table I Incidence, number, histological type, and depth of involvement ofgastric cancers in MNNG-treated rats
Depth of
NVo. of Histology (%) involvement (%)
rats NSo. of Very Muscle
with 2No. of gastric well- Well- Sub- layer
Group Body Weight (g} Effective gastric gastric cancers differ- differ- nucosal or
No. Treatmenta Week 26 Week 52 no. cancer(%ocancers per rat entiated entiated laser deeper
I Olive oil 338±6 396± 7 18 6 (33) 7 0.4±0.1 6 (86) 1 (14) 7 (100) 0 (0)
2 Bromocriptine 334 7 384 11 19 15 (79)' 21 1.1 0.2d 19 (90) 2 (10) 19 (90) 2 (10)
I mg kg-'
3 Bromocriptine 324 8 383 5 20 15 (75)b 19 1.0 0.2b 16 (84) 3 (16) 17 (89) 2 (11)
2mgkg-'
aTreatmentregimens: Oliveoil, 1 ml kg-' ofthevehicle,oliveoil,wasgivens.c. every otherdayafterMNNGtreatmentfor25 weeks; Bromocriptine
1 or 2 mgkg-', I or 2 mg kg-' ofbromocriptine in depot form was given s.c. every other day after MNNG treatment for 25 weeks. bdSignificantly
different from the value for Group 1: bp<0.05; c'P<0.02; dP<O.Ol.DOPAMPNERGIC PROMOTION OF GASTRIC CARCINOGENESIS 353
gastric cancers per rat was 0.4 ± 0.1. The incidence and the
average number of gastric cancers per rat was 79% and
1.1 ± 0.2, respectively, in Group 2 (bromocnrptine at I mg
kg-'), and 75% and 1.0 ± 0.2, respectively, in Group 3
(bromocriptine at 2 mg kg-'): the differences were signifi-
cantly significant from the values for Group 1.
As shown in Table I, all tumours induced in the glandular
stomach were identified histologically as adenocarcinomas.
The distributions of the different histological types of adeno-
carcinomas were not significantly different in the three
groups. No poorly differentiated adenocarcinomas were
found in this series. There was also no significant differences
in the depths of involvement of gastric cancers in the three
groups. All cancers were found in the antral mucosa. with no
metastasis in any rat.
Tissue norepinephrine. labelling index, antralpH, and serwn
gastrin
Table II summarises data on the norepinephrine concentra-
tions in the gastric wall. labelling indices of the gastnrc
mucosa, antral pH's. and serum gastrin levels in the three
groups in week 30 and/or week 52. The tissue norepinephrine
concentrations in the fundic and antral portions of the
stomach were slightly, but not significantly, higher in Groups
2 and 3 (bromocriptine at 1 and 2 mg kg-') than in Group 1
(olive oil). Epinephrine was not detected in any sample
obtained from the gastric wall. In weeks 30 and 52. the
labelling indices of the antral, but not the fundic mucosa in
the bromocriptine-treated Groups 2 and 3 were significantly
higher than that in Group 1 and the antral pH in Group 3
was significantly elevated. There were no significant
differences in the serum gastrin levels in the three different
groups.
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The present study showed that the dopamine agonist bromo-
criptine promoted gastric carcinogenesis induced by MNNG
in Wistar rats. Treatment of rats with bromocriptine in depot
form after 25 weeks of oral treatment with MNNG resulted
in a significant increase in the incidence and number of
gastric cancers in week 52.
The mechanisms of the effect of bromocriptine are not
fully understood. but several possible mechanisms may be
considered. One possibility involves a pharmacological effect
related to serotonin. Some data derived from animal studies
suggest that the serotonin and dopamine system interact
(Gershon & Baldessarni, 1980). Autoradiographic studies in
rat brain have provided anatomical bases for possible inter-
actions at axo-axonal synaptic connections between serotonin
neurons and dopamine nigrostnrated and mesolimbic circuits
(Jenner et al.. 1983). Tutton (1974) found that small amounts
of serotonin increased crypt cell renewal in the jejunum of
the rat.
A second possibility is an effect of dopamine on the
parasympathetic nervous system. Nishikawa et al. (1987)
reported that dopamine inhibits vagally induced gastric acid
secretion through an alpha-2 adrenoceptor-mediated mechan-
ism. However, in studies on the involvement of dopamine
receptors in cholinergic transmission in guinea pig stomach,
Kusunoki et al. (1985) found that dopamine inhibited trans-
mural stimulation-induced 3H-acetylcholine release and con-
cluded that the release of acetylcholine from postganglionic
cholinergic neurons is probably required through dopamine
receptors that were antagonised by D. antagonist. Recently.
we examined the role of the parasympathetic nervous system
in the development of gastric cancers induced by MNNG.
and found that prolonged injections of parasympatholytic
atropine in depot form every other day resulted in a
significant increase in the number of gastric cancers per rat
(Tatsuta et al., 1989). These findings indicate that the para-
sympathetic nervous system is closely involved in the devel-
opment of gastric cancers.
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A third possibility is an effect on the norepinephrine level
in the gastric mucosa. Steardo et al. (1986) observed
significant decrease of plasma norepinephrine in normal or
hypotensive subjects after chronic administration of bromo-
criptine. Baksi et al. (1986) measured the adrenal catechola-
mine concentration in male rats after s.c. treatment with
bromocriptine and haloperidol for 10 days. They found that
bromocriptine-treatment resulted in significant increases in
the dopamine. norepinephrine and epinephrine contents, but
that haloperidol treatment had little or no influence on their
contents. Hrbek et al. (1986) reported that application of
bormocriptine for 10 days significantly decreased the dopa-
mine content, but not the norepinephrine content of the
brain of female rats. In the present work. we found that
prolonged administration of bromocnrptine slightly. but not
significantly, elevated the norepinephrine concentration in
gastric wall.
In the present study administration of the dopamine agon-
ist bromocriptine every other day led to significant increase
in the incidence and number of gastric cancers and in the
labelling indices of the gastric antral mucosa. Although with-
out work with dopaminergic antagonists it seems premature
to ascribe these effects on tumour incidence entirely to its
action on the dopaminergic system. these findings indicate
that the development of gastric cancers is regulated by a
dopaminergic mechanism. and that this mechanism may be
closely related to an effect in increasing proliferation of
antral epithelial cells.
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